Filter
849
Filtered Results: 849
Text search:
Good
Manufacturing
Practices
Featured
Recommendations
73
New Publications
219
Language
Document type
No document type
424
Studies & Reports
170
Guidelines
128
Strategic & Response Plan
47
Manuals
44
Fact sheets
17
Training Material
9
Situation Updates
5
Brochures
2
Resource Platforms
1
Online Courses
1
Videos
1
Countries / Regions
India
42
Kenya
35
Global
32
Ghana
20
Uganda
20
Sierra Leone
19
Nigeria
19
South Africa
18
Africa
17
Western and Central Europe
17
Nepal
16
Ethiopia
16
Tanzania
15
Rwanda
14
Zambia
14
Liberia
11
Philippines
10
Namibia
9
Ukraine
8
Malawi
8
South–East Asia Region
8
Myanmar / Burma
8
Lesotho
7
Zimbabwe
7
Bangladesh
7
Botswana
7
Guinea
6
West and Central Africa
6
East and Southern Africa
6
Indonesia
6
Eswatini/ Swaziland
6
Syria
5
Asia
5
Latin America and the Carribbean
5
Haiti
4
Cambodia
4
Congo, Democratic Republic of
4
Eastern Europe
4
Thailand
3
Eastern Europe and Central Asia
3
Moldova
3
Russia
3
South Sudan
3
Tajikistan
2
Cameroon
2
Albania
2
Laos
2
Senegal
2
USA
2
Middle East and North Africa
2
Western Pacific Region
2
Mauritius
2
Sri Lanka
2
Sudan
2
Pakistan
2
Colombia
1
Turkey
1
Australia
1
Benin
1
China
1
Burkina Faso
1
Afghanistan
1
Peru
1
Mozambique
1
Venezuela
1
Germany
1
Turkmenistan
1
Maldives
1
United Kingdom
1
Bosnia and Herzegovina
1
Ecuador
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
328
Clinical Guidelines
50
Key Resources
48
Public Health
44
Pharmacy & Technologies
34
Women & Child Health
19
Capacity Building
7
Toolboxes
Pharmacy
86
COVID-19
72
AMR
67
HIV
52
Planetary Health
43
TB
29
Rapid Response
24
Mental Health
20
NTDs
19
Ebola & Marburg
18
Disability
17
Global Health Education
16
Health Financing Toolbox
15
NCDs
14
Conflict
14
Specific Hazards
13
Natural Hazards
11
Refugee
9
Caregiver
6
Cholera
4
Polio
3
Zika
2
Malaria
1
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these...
Spread of resistance to antimicrobial agents (AMR) does not know national borders and has reached dimensions, which require immediate actions at the national, regional and global levels.
Antibiotic resistance is a natural biological response to improper use of antimicrobial agents (AMA); increasing...
The second edition of the joint WHO, WIPO and WTO
publication “Promoting Access to Medical Technologies
and Innovation: Intersections between public health,
intellectual property and trade” (the Trilateral Study),*
published in 2020, included a special insert mappi...
South Africa has faced many challenges over the past two decades, accomplishing profound positive changes in the social structure and government of the nation. This has not yet fully translated into better health for the population, however, particularly the poorest segment. In fact, the p...
Antimicrobial resistance (AMR) is an important public health concern shared by developed and developing countries. In developing countries the burden of infectious diseases is greater and exacerbated by limited access to, and availability and affordability of, antimicrobials required to treat infect...
Published:February 02, 2021DOI:https://doi.org/10.1016/S0140-6736(21)00234-8
PQDx 0144-043-00 WHO
PQDx Public Report
November/2016, version 4.0
Antibiotics and other antimicrobial agents are invaluable life savers, particularly in resource-limited countries where infectious diseases are abundant. Both uncomplicated and severe infections are potentially curable as long as the aetiological agents are susceptible to the ...
The UNICEF-GAIN Partnership Project
The report notes that iodine deficiency is a leading cause of preventable brain damage worldwide. Insufficient iodine during pregnancy and infancy results in neurological and psychological deficits, reducing a child’s IQ by 8 to 10 points. This translates ...
The report notes that iodine deficiency is a leading cause of preventable brain damage worldwide. Insufficient iodine during pregnancy and infancy results in neurological and psychological deficits, reducing a child’s IQ by 8 to 10 points. This translates ...
To support its R&D activities on Chagas disease, DNDi launched the Chagas Clinical Research Platform (CCRP). The platform brings together partners, experts, and stakeholders to provide support for evaluation and development of new treatments for Chagas disease. The patient-centred platform aims to f...
Examination of the business behaviour of Boehringer Ingelheim, Bayer and Baxter in Uganda
PQDx 0214-064-00
WHO PQDx PR
April/2016, version 3.0
This Pharmaceutical Country Profile for Kenya (2010) has been developed by the Ministry of Medical Services with support of the World Health Organization. The Profile contains information on existing socio-economic and health-related conditions, resources, regulatory structures and processes and out...
